-
Seres Therapeutics' (MCRB) Buy Rating Reaffirmed at Canaccord Genuity Group
ソース: Buzz FX / 14 11 2024 12:31:18 America/New_York
Seres Therapeutics' (MCRB) Buy Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Seres Therapeutics ( NASDAQ:MCRB - Get Free Report ) 's stock had its "buy" rating reiterate
Read more...